↓ Skip to main content

PLOS

Can Antidepressants Prevent Pegylated Interferon-α/Ribavirin-Associated Depression in Patients with Chronic Hepatitis C: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials?

Overview of attention for article published in PLOS ONE, October 2013
Altmetric Badge

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
68 Mendeley
Title
Can Antidepressants Prevent Pegylated Interferon-α/Ribavirin-Associated Depression in Patients with Chronic Hepatitis C: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials?
Published in
PLOS ONE, October 2013
DOI 10.1371/journal.pone.0076799
Pubmed ID
Authors

Xin-Jiang Hou, Jing-Hang Xu, Jun Wang, Yan-Yan Yu

Abstract

Antidepressants are effective in treating interferon-α/ribavirin (IFN-α/RBV)-associated depression during or after treatment of chronic hepatitis C (CHC). Whether antidepressant prophylaxis is necessary in this population remains under debate.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 67 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 16%
Researcher 10 15%
Student > Ph. D. Student 9 13%
Student > Doctoral Student 8 12%
Student > Bachelor 7 10%
Other 17 25%
Unknown 6 9%
Readers by discipline Count As %
Medicine and Dentistry 25 37%
Psychology 7 10%
Agricultural and Biological Sciences 5 7%
Neuroscience 5 7%
Social Sciences 3 4%
Other 13 19%
Unknown 10 15%